Biotechnology, particularly medicinal-focused biotechnology, has garnered a lot of attention lately for making significant technological advances in improving human and animal health, notably with the advent of COVID-19 new medicines. Biotechnology, on the other hand, is driving advancements in bio-based materials, consumer goods, and chemicals. This subcategory, known as industrial biotechnology, involves producing bio-based polymers and synthetic fabrics, as well as conceptualising new uses for previously wasted biomass waste. Industrial biotechnologists are spearheading an amazing effort to develop environmentally friendly and cost-effective manufacturing solutions. The need for bio manufactured items are increasing, from vaccines to meat alternatives. However, the large-scale biomanufacturing infrastructure required to commercialise all of these products has been lacking. To meet the demand for fermentation-based animal protein by 2030, worldwide biomanufacturing capacity will have to rise 100 times.